Canada markets open in 4 hours 13 minutes

Amphastar Pharmaceuticals, Inc. (AMPH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
42.37+0.16 (+0.38%)
At close: 04:00PM EDT
44.38 +2.01 (+4.74%)
After hours: 05:43PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.07B
Enterprise Value 2.41B
Trailing P/E 14.56
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)3.34
Price/Book (mrq)3.08
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 26.99

Trading Information

Stock Price History

Beta (5Y Monthly) 0.85
52-Week Change 3-1.33%
S&P500 52-Week Change 327.04%
52 Week High 367.66
52 Week Low 338.43
50-Day Moving Average 342.54
200-Day Moving Average 350.62

Share Statistics

Avg Vol (3 month) 3420.32k
Avg Vol (10 day) 3374.26k
Shares Outstanding 548.9M
Implied Shares Outstanding 648.9M
Float 838.1M
% Held by Insiders 122.01%
% Held by Institutions 170.16%
Shares Short (Apr 30, 2024) 43.99M
Short Ratio (Apr 30, 2024) 412.02
Short % of Float (Apr 30, 2024) 412.43%
Short % of Shares Outstanding (Apr 30, 2024) 48.16%
Shares Short (prior month Mar 28, 2024) 43.67M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 22.88%
Operating Margin (ttm)27.94%

Management Effectiveness

Return on Assets (ttm)11.26%
Return on Equity (ttm)25.34%

Income Statement

Revenue (ttm)676.21M
Revenue Per Share (ttm)13.99
Quarterly Revenue Growth (yoy)22.70%
Gross Profit (ttm)N/A
EBITDA 256.09M
Net Income Avi to Common (ttm)154.69M
Diluted EPS (ttm)2.91
Quarterly Earnings Growth (yoy)65.90%

Balance Sheet

Total Cash (mrq)289.56M
Total Cash Per Share (mrq)5.92
Total Debt (mrq)627.12M
Total Debt/Equity (mrq)93.27%
Current Ratio (mrq)2.17
Book Value Per Share (mrq)13.77

Cash Flow Statement

Operating Cash Flow (ttm)198.41M
Levered Free Cash Flow (ttm)255.52M